{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:07:06Z","timestamp":1788174426271,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Precancerous lesions are the most commonly cited factor in gastric cancer etiology. The sequence of events in intestinal-type gastric carcinogenesis is considered to be chronic gastritis, atrophy, intestinal metaplasia (IM), dysplasia, and carcinoma, respectively. Early diagnosis and treatment of advanced precursor lesions and gastric cancer is possible by identifying and monitoring patients with such premalignant lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>In our study, we aimed to evaluate the long-term follow-up results of intestinal metaplasia in our hospital and the rate of progression to malignancy by comparing these patients with patients who have undergone gastroscopy without a diagnosis of intestinal metaplasia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>One hundred and fifty-six followed-up patients out of 700 between the ages of 18 and 85 who were admitted to our hospital between 2009 and 2019, who were diagnosed with IM by pathological examination from biopsy material, and 150 patients who were not diagnosed with IM between 2009 and 2011 were included. The results of the cases were evaluated first retrospectively; then, the patients who were invited for control and underwent endoscopy were evaluated prospectively. IM and control groups were compared in terms of dysplasia and gastric cancer development. In addition, the IM group was compared in terms of 5 and 10 years of follow-up, extensive or local involvement, and complete and incomplete involvement in terms of dysplasia and cancer development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The follow-up period of the patients ranged from 1 to 10 years, and the mean follow-up interval was 4.2 \u00b1 2.8 (min: 1; max: 10) years. Age, gender, and pathology results of the patients were examined in terms of IM type, localization of IM, pathology accompanying IM, and presence of Helicobacter pylori (Hp) infection and compared with the control group. While gastric carcinoma was detected in three of 156 patients in the IM group, gastric carcinoma was not detected in the follow-up of 150 patients in the control group. IM was most common in the antrum. Incomplete IM was detected in 89 patients, and complete IM in 69 patients. While two of the three patients with gastric carcinoma were localized to the antrum, one patient had incomplete-type IM and two patients had complete-type IM, and Hp was positive in two patients. While dysplasia was detected in nine of the patients diagnosed with IM, it was detected in two patients in the control group. A statistically significant difference was found between the IM and control groups in terms of dysplasia positivity (p = 0.037). On the other hand, no statistically significant difference was found between the IM and control groups in terms of age-group, gender, follow-up time group, and Hp positivity (p &gt; 0.05). There was no significant difference between those who were followed up for 5 and 10 years in the IM group in terms of dysplasia and cancer development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Therefore, it is considered that patients with intestinal metaplasia may be followed up at longer intervals, except for patients with race, ethnicity, incomplete type, extensive involvement, and a family history of gastric cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_1548_21","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:49:43Z","timestamp":1647409783000},"page":"315-324","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Gastric intestinal metaplasia"],"prefix":"10.4103","volume":"25","author":[{"given":"H","family":"Rakici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Uyanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IM","family":"Rakici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HB","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Akdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Ayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20240907","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-16-20240907","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/bmj.323.7326.1413","article-title":"ABC of the upper gastro intestinal tract: Cancer of the stomach and pancreas","volume":"323","author":"Bowles","year":"2001","journal-title":"BMJ"},{"key":"R3-16-20240907","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: Cohort follow-up","volume":"50","author":"Correa","year":"1990","journal-title":"Cancer Res"},{"key":"R4-16-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2007.00475.x","article-title":"The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection","volume":"12","author":"Vries","year":"2007","journal-title":"Helicobacter"},{"key":"R5-16-20240907","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.50.3.378","article-title":"The long term results of endoscopic surveillance of premalignant gastric lesions","volume":"50","author":"Whiting","year":"2002","journal-title":"Gut"},{"key":"R6-16-20240907","first-page":"17","article-title":"Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: Increase in the signet ring cell type","volume":"2006","author":"Bejarano","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R7-16-20240907","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two h\u0131stolog\u0131cal ma\u0131n types of gastr\u0131c carc\u0131noma: d\u0131ffuse and so-called \u0131ntest\u0131nal-type carc\u0131noma: An Attempt at a Histo-Clinical Classification","volume":"64","author":"Laur\u00e9n","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R8-16-20240907","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1746.2008.05774.x","article-title":"Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesis","volume":"24","author":"Busuttil","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-16-20240907","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/gut.26.12.1319","article-title":"Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres","volume":"26","author":"Filipe","year":"1985","journal-title":"Gut"},{"key":"R10-16-20240907","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5009\/gnl19181","article-title":"Diagnosis and management of gastric intestinal metaplasia: Current status and future directions","volume":"13","author":"Huang","year":"2019","journal-title":"Gut Liver"},{"key":"R11-16-20240907","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gut.52.6.807","article-title":"Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma","volume":"52","author":"Mirza","year":"2003","journal-title":"Gut"},{"key":"R12-16-20240907","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1365-2036.2002.01300.x","article-title":"Intestinal metaplasia and gastric carcinogenesis","volume":"16","author":"Leung","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-16-20240907","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade: The gastric precancerous cascade","volume":"13","author":"Correa","year":"2012","journal-title":"J Dig Dis"},{"key":"R14-16-20240907","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands","volume":"134","author":"De Vries","year":"2008","journal-title":"Gastroenterology"},{"key":"R15-16-20240907","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"R16-16-20240907","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ajg.2016.188","article-title":"Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: A population-based study","volume":"111","author":"Li","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"R17-16-20240907","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.gie.2016.03.791","article-title":"Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication","volume":"84","author":"Shichijo","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R18-16-20240907","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1007\/s10620-019-06031-5","article-title":"Increased risk of progression to gastric adenocarcinoma inpatients with non-dysplastic gastric intestinal metaplasia versus a control population","volume":"65","author":"Dhingra","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R19-16-20240907","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jcp.2003.11270","article-title":"A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia","volume":"57","author":"Dinis-Ribeiro","year":"2004","journal-title":"J Clin Pathol"},{"key":"R20-16-20240907","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ijc.28003","article-title":"Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence: Subtypes of intestinal metaplasia and gastric cancer risk","volume":"133","author":"Gonz\u00e1lez","year":"2013","journal-title":"Int J Cancer"},{"key":"R21-16-20240907","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.54.9.679","article-title":"Gastric intestinal metaplasia: Subtypes and natural history","volume":"54","author":"El-Zimaity","year":"2001","journal-title":"J Clin Pathol"},{"key":"R22-16-20240907","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1572-0241.2000.02074.x","article-title":"Topographic patterns of intestinal metaplasia and gastric cancer","volume":"95","author":"Cassaro","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R24-16-20240907","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-8553(02)00012-2","article-title":"Role of Helicobacter pylori in gastric carcinogenesis","volume":"31","author":"Sepulveda","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"R25-16-20240907","first-page":"12","article-title":"Endoskopik olarak tan\u0131mlanan gastritile histolojik bulgular aras\u0131ndaki ili\u015fki","volume":"8","author":"\u0130bi\u015f","year":"2009","journal-title":"Akad Gastroenteroloji Derg"},{"key":"R26-16-20240907","first-page":"1563","article-title":"Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey","volume":"57","author":"Ozdil","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"R27-16-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15321\/GenelTipDer.20142014\/16362","article-title":"Tekirda\u011f b\u00f6lgesinde Helicobacter pylori prevalans\u0131 ve patolojikparametrelerin \u00e7ok y\u00f6nl\u00fc analizi; literat\u00fcr ile g\u00fcncelleme","volume":"24","author":"Mete","year":"2014","journal-title":"Genel Tip Derg"},{"key":"R28-16-20240907","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jgh.15017","article-title":"Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication","volume":"35","author":"Noh","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R30-16-20240907","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/0008-5472.CAN-18-2268","article-title":"Smoking and urinary cotinine levels are predictors of increased risk for gastric intestinal metaplasia","volume":"79","author":"Kim","year":"2019","journal-title":"Cancer Res"},{"key":"R31-16-20240907","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","article-title":"Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"key":"R32-16-20240907","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","article-title":"Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer","volume":"20","author":"Park","year":"2015","journal-title":"J Cancer Prev"},{"key":"R33-16-20240907","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/jgh.13313","article-title":"Meta-analysis: The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions: Diagnostic efficacy of chromoendoscopy","volume":"31","author":"Zhao","year":"2016","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1548_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:32Z","timestamp":1787166512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1548_21"}},"subtitle":["Long-term follow-up results"],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_1548_21","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}